Norwood Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.39M Buy
7,625
+25
+0.3% +$4.31K 2% 8
2023
Q4
$1.18M Sell
7,600
-264
-3% -$38.5K 1.79% 9
2023
Q3
$1.17M Sell
7,864
-215
-3% -$31.6K 1.9% 9
2023
Q2
$1.09M Sell
8,079
-101
-1% -$14.8K 1.63% 11
2023
Q1
$1.3M Hold
8,180
2.07% 7
2022
Q4
$1.32M Hold
8,180
2.08% 7
2022
Q3
$1.1M Hold
8,180
1.94% 8
2022
Q2
$1.25M Sell
8,180
-5
-0.1% -$764 2.14% 8
2022
Q1
$1.33M Hold
8,185
1.93% 9
2021
Q4
$1.11M Buy
+8,185
New +$967K 1.54% 15

Other funds holding ABBV

Norwood Financial's ABBV Position: Q1 2024 in Review

Norwood Financial increased its AbbVie (ABBV) stake by 0.33% in Q1 2024, buying an estimated $4.31K and bringing the position to 7,625 shares worth $1.39M. The position accounts for 2% of the portfolio, ranked #8.

Norwood Financial first reported a position in ABBV in Q4 2021 and has held it in 10 quarters since. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Norwood Financial held 7,625 shares of AbbVie worth $1.39M as of Q1 2024.
  • Norwood Financial bought 25 AbbVie shares in Q1 2024, an estimated $4.31K.
  • AbbVie made up 2% of Norwood Financial's portfolio in Q1 2024, its #8 holding.
  • Norwood Financial first reported a position in AbbVie in Q4 2021 and has held it in 10 quarters since.
  • 3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.